BIND Therapeutics: JMP Securities Life Sciences Conference (BIND Therapeutics) - Jun 27, 2015 - Anticipated final stage 1 data readout from P2 iNSITE 2 trial for bladder, cervical, cholangio and head and neck cancer in H1 2016; Anticipated stage 2 data readout from P2 iNSITE 2 for bladder, cervical, cholangio and head and neck cancer in H2 2016
Anticipated P2 data • Head and Neck Cancer • Oncology
|